Scilex Holding Co current report, 11 January 2021

Business Context and Reporting Period

This Form 8-K was filed by Vickers Vantage Corp. I, not Scilex Holding Co., for an event dated January 11, 2021. The filing reports the closing of the company’s initial public offering and related private placement. Vickers Vantage Corp. I was a Cayman Islands special purpose acquisition company and had not yet completed its initial business combination.

Key Financial and Capitalization Metrics

  • The IPO included 13,800,000 units, including 1,800,000 units issued pursuant to the underwriters’ over-allotment option.
  • Each unit consisted of one ordinary share and one-half of one redeemable warrant.
  • Units were sold at $10.00 each, generating gross IPO proceeds of $138.0 million.
  • Each public warrant entitles its holder to purchase one ordinary share at an exercise price of $11.50 per share.
  • The company also issued 6,840,000 private placement warrants to its sponsors at $0.75 per warrant, generating proceeds of $5.13 million.
  • The filing text does not provide net proceeds, offering expenses, cash flow, operating revenue, profit, margins, debt, or liquidity balances.
  • An audited balance sheet as of January 11, 2021 was filed as Exhibit 99.1, but its detailed amounts are not included in the provided filing text.

Material Changes Versus the Prior Comparable Period

The filing describes a financing transaction rather than periodic operating results. It does not provide comparative financial statements or quantify changes versus a prior period. The material change was the receipt of IPO and private placement proceeds and the issuance of ordinary shares and warrants.

Guidance, Outlook, Risks, and Unusual Items

  • The filing does not provide financial guidance or operating forecasts.
  • The proceeds were raised in connection with the company’s status as a SPAC and were intended to support its future initial business combination; the filing does not identify a target or transaction terms.
  • Private placement warrants are non-redeemable and may be exercised on a cashless basis while held by the initial holders or permitted transferees.
  • The sponsors agreed not to transfer, assign, or sell the private placement warrants or the underlying ordinary shares, subject to specified permitted transfers, until after completion of the initial business combination.
  • The filing includes an audited balance sheet and a press release as exhibits, but the provided text does not include the balance sheet details or additional risk disclosures.

Investor Verification Items

  • Confirm the issuer identity: the filing names Vickers Vantage Corp. I, whereas the request metadata identifies Scilex Holding Co.
  • Review Exhibit 99.1 for cash, offering costs, liabilities, and shareholders’ equity after the offering.
  • Verify the final number of public shares, public warrants, and private placement warrants outstanding.
  • Review the warrant terms, including redemption provisions, cashless exercise conditions, and transfer restrictions.
  • Determine how and when the company used the proceeds and whether an initial business combination was subsequently completed.